GREEN BAY, WI — David Novak, a patient at the Hemophilia Outreach Center, made history as the first Wisconsinite — and only the second person in the nation — to receive the newly FDA-approved gene therapy treatment ROCTAVIAN for hemophilia A. This breakthrough offers hope for reducing or eliminating the need for regular infusions and marks a major milestone for the hemophilia community.
Common Misconceptions About Bleeding Disorders with Andrea Buxton and Sumedha Ghate
Today on Beyond the Bleeds, we sit down with Sumedha Ghate, a genetic counselor at HOC, and Andrea Buxton, HOC’s nurse practitioner and clinical director, to break down some of the most common misconceptions about bleeding disorders. From the belief that someone with...

